cancer-associated splicing variant of tumor suppressor aimp2p38 pathological implication in tumorigenesis癌症相关的肿瘤抑制的剪接变体aimp2p38病理肿瘤发生的影响.pdfVIP

Cancer-Associated Splicing Variant of Tumor Suppressor AIMP2/p38: Pathological Implication in Tumorigenesis 1 1 1 1 1 1 Jin Woo Choi , Dae Gyu Kim , Al-Eum Lee , Hye Rim Kim , Jin Young Lee , Nam Hoon Kwon , Young Kee 2 3 3 3 4 5 Shin , Soon-Kyung Hwang , Seung-Hee Chang , Myung-Haing Cho , Yoon-La Choi , Jhingook Kim , 6 6 6 7 8 9 Seung Hyun Oh , Bora Kim , Soo-Youl Kim , Hyo-Sung Jeon , Jae Yong Park , Hyunseok Peter Kang , Bum Joon Park10, Jung Min Han1,11, Sunghoon Kim 1,11* 1 Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea, 2 Laboratory of Molecular Pathology, College of Pharmacy, Seoul National University, Seoul, Korea, 3 College of Veterinary Medicine, Seoul National University, Seoul, Korea, 4 Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, 5 Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, 6 National Cancer Center, Research Institute, Goyang, Korea, 7 Department of Biochemistry, School of Medicine, Kyungpook National University, Daegu, Korea, 8 Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea, 9 Department of Pathology and Laboratory Medicine, Roswell Cancer Park Institute, Buffalo, New York, United States of America, 10 Department of Molecular Biology, Pusan National University, Pusan, Korea, 11 WCU Department of Mo